Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Reckitt shortlists bidders for $2 billion Mead Johnson China business - sources

Published 05/14/2021, 01:13 AM
Updated 05/14/2021, 02:40 AM
© Reuters. FILE PHOTO: Products produced by Reckitt Benckiser; Vanish, Finish, Dettol and Harpic, are seen in London, Britain February 12, 2008.   REUTERS/Stephen Hird

By Kane Wu

HONG KONG (Reuters) - British consumer goods company Reckitt Benckiser Group has shortlisted bidders including Bain Capital, Carlyle Group (NASDAQ:CG) and dairy producer Yili to submit binding offers for its Greater China infant formula business, sources said.

The group has hired Morgan Stanley (NYSE:MS) to run an auction of infant formula unit Mead Johnson in Greater China, in a deal that could fetch over $2 billion. Morgan Stanley declined to comment.

Also on the shortlist are Sequoia Capital China teaming up with its portfolio company Shijiazhuang Junlebao Dairy Co, and private equity firm KKR & Co (NYSE:KKR), said the sources, who declined to be named as the information is confidential.

Carlyle is bidding jointly with CITIC Capital, said two of the people.

Shortlisted bidders are to submit binding bids by June 11, said another two of the sources.

Bain, Carlyle, KKR and Sequoia China declined to comment. Reckitt, CITIC Capital, Junlebao and Inner Mongolia Yili Industrial Group did not immediately respond to requests for comment.

Reckitt's sale of Mead Johnson China comes as the world's second largest economy this week reported its slowest population increase since the first modern population survey in the 1950s, with birth rates declining to the levels seen in ageing societies like Japan and Italy.

The exit also follows French dairy giant Danone which sold its 9.8% stake in China Mengniu Diary this week for about $1.6 billion euros.

Some investors are wary of how China's demographic shift is going to impact the infant formula industry, said the sources.

Hong Kong border closures during the pandemic has also weighed in on Reckitt's infant formula business, its executives have said.

Reckitt's Greater China infant formula business represents 6% of group sales, which were almost 14 billion pounds ($19.8 billion) in 2020, up 11.8% year-on-year, it said in February.

U.S.-headquartered Mead Johnson, which Reckitt bought for $16.6 billion in 2017, runs a range of infant formula brands including Enfamil, Enfapro and Lactum.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.